These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15941215)

  • 41. Density functional theory (DFT) and combined quantum mechanical/molecular mechanics (QM/MM) studies on the oxygen activation step in nitric oxide synthase enzymes.
    de Visser SP
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):373-7. PubMed ID: 19290865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism-based inactivation and reversibility: is there a new trend in the inactivation of cytochrome p450 enzymes?
    Blobaum AL
    Drug Metab Dispos; 2006 Jan; 34(1):1-7. PubMed ID: 16369051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanohybrids composed of quantum dots and cytochrome P450 as photocatalysts.
    Ipe BI; Niemeyer CM
    Angew Chem Int Ed Engl; 2006 Jan; 45(3):504-7. PubMed ID: 16365841
    [No Abstract]   [Full Text] [Related]  

  • 44. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron oxidation state modulates active site structure in a heme peroxidase.
    Badyal SK; Metcalfe CL; Basran J; Efimov I; Moody PC; Raven EL
    Biochemistry; 2008 Apr; 47(15):4403-9. PubMed ID: 18351739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alkane hydroxylation by peroxy acids: a comparison with the cytochrome P450 hydroxylation.
    Groenhof AR; Ehlers AW; Lammertsma K
    J Phys Chem A; 2008 Dec; 112(50):12855-61. PubMed ID: 18956858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for cytochrome p450 reactivity by harnessing catalase as reporter enzyme.
    Rabe KS; Spengler M; Erkelenz M; Müller J; Gandubert VJ; Hayen H; Niemeyer CM
    Chembiochem; 2009 Mar; 10(4):751-7. PubMed ID: 19241405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A diiron center stabilized by a bis-TPA ligand as a model of soluble methane monooxygenase: predominant alkene epoxidation with H2O2.
    Kodera M; Itoh M; Kano K; Funabiki T; Reglier M
    Angew Chem Int Ed Engl; 2005 Nov; 44(43):7104-6. PubMed ID: 16217818
    [No Abstract]   [Full Text] [Related]  

  • 50. Ferric and ferrous iron in nitroso-myoglobin: computer simulations of stable and metastable States and their infrared spectra.
    Nutt DR; Meuwly M
    Chemphyschem; 2007 Mar; 8(4):527-36. PubMed ID: 17330815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design of and mechanistic studies on a biomimetic iron-imidazole catalyst system for epoxidation of olefins with hydrogen peroxide.
    Schröder K; Enthaler S; Bitterlich B; Schulz T; Spannenberg A; Tse MK; Junge K; Beller M
    Chemistry; 2009; 15(22):5471-81. PubMed ID: 19370748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple oxidants and multiple mechanisms in cytochrome P450 catalysis.
    Coon MJ
    Biochem Biophys Res Commun; 2003 Dec; 312(1):163-8. PubMed ID: 14630036
    [No Abstract]   [Full Text] [Related]  

  • 53. Oxidizing species in the mechanism of cytochrome P450.
    Ortiz de Montellano PR; De Voss JJ
    Nat Prod Rep; 2002 Aug; 19(4):477-93. PubMed ID: 12195813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Encapsulation, storage and controlled release of sulfur hexafluoride from a metal-organic capsule.
    Riddell IA; Smulders MM; Clegg JK; Nitschke JR
    Chem Commun (Camb); 2011 Jan; 47(1):457-9. PubMed ID: 20871932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Interpretation of the resonance Raman spectrum of cytochrome P-450].
    Gladkov LL; Solov'ev KN
    Biofizika; 1997; 42(1):26-33. PubMed ID: 9181798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Physiological function, reaction mechanism, and structure of cytochrone P450nor].
    Shoun H; Fushinobu S
    Seikagaku; 2008 Jun; 80(6):560-8. PubMed ID: 18634431
    [No Abstract]   [Full Text] [Related]  

  • 57. The experimentally elusive oxidant of cytochrome P450: a theoretical "trapping" defining more closely the "real" species.
    Ogliaro F; de Visser SP; Cohen S; Kaneti J; Shaik S
    Chembiochem; 2001 Nov; 2(11):848-51. PubMed ID: 11948872
    [No Abstract]   [Full Text] [Related]  

  • 58. Iron-Based Nanozymes in Disease Diagnosis and Treatment.
    Shi C; Li Y; Gu N
    Chembiochem; 2020 Oct; 21(19):2722-2732. PubMed ID: 32315111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystallography gets the jump on the enzymologists.
    Ballou DP
    Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15587-8. PubMed ID: 17898164
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular modeling: an experimental tool.
    Darden TA; Pedersen LG
    Environ Health Perspect; 1993 Oct; 101(5):410-2. PubMed ID: 8119250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.